Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.46 |
| ▸ | HRAS | P01112 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9238485 | 1.00 | LGALS8 (0.61) | LGALS8CA2CA9CA1POLB | |
| SCHEMBL8537938 | 1.00 | LGALS8 (0.61) | LGALS8CA2CA9CA1POLB | |
| SCHEMBL12501263 | 0.91 | LGALS8 (0.64) | LGALS8CA2CA9CA1LGALS3 | |
| SCHEMBL12501267 | 0.91 | LGALS8 (0.64) | LGALS8CA2CA9CA1LGALS3 | |
| SCHEMBL7768969 | 0.90 | LGALS8 (0.51) | LGALS8CA2CA9CA1POLB | |
| SCHEMBL11072562 | 0.90 | LGALS8 (0.57) | LGALS8CA2CA9CA1POLB | |
| SCHEMBL28275633 | 0.89 | LGALS8 (0.62) | LGALS8CA2CA9CA1LGALS3 | |
| SCHEMBL10524069 | 0.89 | LGALS8 (0.62) | LGALS8CA2CA9CA1LGALS3 | |
| SCHEMBL11068273 | 0.88 | LGALS8 (0.53) | LGALS8CA2CA9CA1LGALS3 | |
| SCHEMBL11078253 | 0.88 | LGALS8 (0.56) | LGALS8CA2CA9CA1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-55081900-A | — | — | None | — | — | JP | disclosed |
| US-5849709-A | Saccharopeptides and derivatives thereof | GLYCOMED INCORPORATED (US) | 1998-12-15 | — | — | US | disclosed |
| EP-0824538-A1 | SACCHAROPEPTIDES AND DERIVATIVES THEREOF | GLYCOMED INCORPORATED (US) | 1998-02-25 | — | — | EP | disclosed |
| WO-1996035700-A9 | SACCHAROPEPTIDES AND DERIVATIVES THEREOF | — | 1997-02-13 | — | — | WO | disclosed |
| WO-1996035700-A1 | SACCHAROPEPTIDES AND DERIVATIVES THEREOF | GLYCOMED INCORPORATED (US) | 1996-11-14 | — | — | WO | disclosed |
| US-5380716-A | Anticoagulants | GLYCOMED, INC. (US) | 1995-01-10 | — | — | US | disclosed |
| WO-1994014849-A1 | SULFATED POLYSACCHARIDES AS INHIBITORS OF SMOOTH MUSCLE CELL PROLIFERATION | GLYCOMED INCORPORATED (US) | 1994-07-07 | — | — | WO | disclosed |
| EP-0582665-A1 | SULFATED POLYSACCHARIDES AS INHIBITORS OF SMOOTH MUSCLE CELL PROLIFERATION | GLYCOMED INCORPORATED (US) | 1994-02-16 | — | — | EP | disclosed |
| WO-1992018546-A1 | SULFATED POLYSACCHARIDES AS INHIBITORS OF SMOOTH MUSCLE CELL PROLIFERATION | GLYCOMED, INC. (US) | 1992-10-29 | — | — | WO | disclosed |
| EP-0062329-B1 | NOVEL NITROSOUREA DERIVATIVE, PROCESS FOR PREPARING SAME AND THERAPEUTIC COMPOSITION CONTAINING SAID DERIVATE | Tanabe Seiyaku Co., Ltd. (JP) | 1985-02-20 | — | — | EP | disclosed |
| US-4472573-A | ANTITUMOR, ANTILEUKEMIC | TANABE SEIYAKU CO., LTD. (JP) | 1984-09-18 | — | — | US | disclosed |
| US-4472379-A | ANTILEUKEMIA AGENTS | SUAMI T (JP) | 1984-09-18 | — | — | US | disclosed |
| JP-S5581900-A | PREPARATION OF COMBINED STEROID HORMONE DERIVATIVE- ANTITUMOR SUBSTANCE | KUREHA CHEM IND CO LTD | 1980-06-20 | — | — | JP | disclosed |